Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-24 @ 12:23 PM
NCT ID:
NCT00568061
Eligibility Criteria:
Inclusion Criteria:
* Acute myocardial infarction and electrocardiographic evidence of ST elevation
* No clinical evidence of congestive heart failure
* All patients must undergo successful percutaneous coronary intervention for thrombolysis in myocardial infarction (TIMI) 0 or 1 coronary flow with resulting TIMI 2 or 3 flow
* Greater than 18 years of age
* Signed Institutional Review Board (IRB) approved informed consent
Exclusion Criteria:
* Prior myocardial infarction
* Requirement for urgent cardiac surgery
* Previous coronary artery bypass graft (CABG) or primary coronary intervention (PCI)
* Left bundle branch block
* Heart block that is expected to require a temporary pacemaker for greater than 72 hours
* Prior use of thrombolytic therapy for the current event
* Unable to tolerate magnetic resonance imaging or unable to tolerate gadolinium contrast media, including patients with a calculated creatinine clearance less than 60 ml/min/1.73m² Body Surface Area (BSA)
* Active or recent hemorrhage requiring an invasive procedure for evaluation or transfusion within 6 weeks prior to presentation, or hemorrhagic stroke within the 6 weeks prior
* Neutropenia (WBC \<2000 (mm)³), Anemia (HCT \<30%, Thrombocytopenia (Thrombocytes \<50,000 (mm)³). It is not necessary to confirm blood counts prior to start of study drug in the absence of clinical suspicion.
* Known or suspected aortic dissection.
* Prior history of pulmonary disease requiring chronic oxygen therapy.
* Pregnancy, lactating, and women of childbearing potential.
* Medical problem likely to preclude completion of the study.
* Use of investigational drugs or device within the 30 days prior to enrollment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00568061
Study Brief:
Protocol Section:
NCT00568061